Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 1 | 20K | ||||||||
| Other cash income from operating activities | ---- | --1 | ---- | ---- | --20K | ---- | ---- | ---- | ---- | ---- |
| Cash paid | -144.22%-1.36M | 23.55%-556.36K | 78.60%-727.72K | -48.07%-3.4M | -173.19%-2.3M | 22.22%-840.63K | 57.52%-1.08M | -76.68%-2.54M | 31.73%-1.44M | -205.83%-2.11M |
| Payments to suppliers for goods and services | -144.22%-1.36M | 23.55%-556.36K | 14.46%-727.72K | -354.39%-850.77K | 59.96%-187.23K | 36.63%-467.57K | 57.01%-737.87K | -23.18%-1.72M | 33.19%-1.39M | -259.22%-2.09M |
| Other cash payments from operating activities | ---- | ---- | ---- | -20.87%-2.55M | -465.40%-2.11M | -8.77%-373.06K | 58.58%-342.98K | -1,669.92%-827.97K | -95.78%-46.78K | 78.11%-23.89K |
| Direct interest paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.33K | ---- |
| Direct interest received | 834.87%62.25K | -67.24%6.66K | 86.87%20.33K | 64.53%10.88K | 40.60%6.61K | 190.61%4.7K | -94.28%1.62K | 102.24%28.29K | 124.15%13.99K | 3,465.71%6.24K |
| Operating cash flow | -135.85%-1.3M | 22.29%-549.7K | 79.13%-707.4K | -49.32%-3.39M | -171.54%-2.27M | 22.54%-835.93K | 57.10%-1.08M | -76.26%-2.52M | 32.13%-1.43M | -205.00%-2.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -149.61%-2.64M | 26.06%-1.06M | -1.43M | 98.28%-4.03K | -234.81K | -2,116.11%-667.56K | ||||
| Capital expenditure reported | -157.49%-2.71M | 26.43%-1.05M | ---1.43M | ---- | ---- | ---- | ---- | ---200K | ---- | ---- |
| Net PPE purchase and sale | 1,387.31%69.46K | ---5.4K | ---- | ---- | ---- | ---- | 98.43%-4.03K | ---256.58K | ---- | ---- |
| Net other investing changes | ---- | --1 | ---- | ---- | ---- | ---- | ---- | --221.77K | ---- | ---667.56K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -149.61%-2.64M | 26.06%-1.06M | ---1.43M | ---- | ---- | ---- | 98.28%-4.03K | ---234.81K | ---- | -2,116.11%-667.56K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 148.20%4.53M | 1.83M | 92.01%4.98M | 88.31%2.59M | 249.77%1.38M | -78.91%393.68K | -36.00%1.87M | -1.39%2.92M | 333.70%2.96M | |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | --200K | ---- | -13.29%286.14K | --330K |
| Net common stock issuance | 148.20%4.53M | --1.83M | ---- | 101.32%4.98M | 79.60%2.47M | 610.95%1.38M | -89.62%193.68K | -29.04%1.87M | 0.10%2.63M | 296.95%2.63M |
| Net other financing activities | ---- | ---- | ---- | ---- | --120K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 148.20%4.53M | --1.83M | ---- | 92.01%4.98M | 88.31%2.59M | 249.77%1.38M | -78.91%393.68K | -36.00%1.87M | -1.39%2.92M | 333.70%2.96M |
| Net cash flow | ||||||||||
| Beginning cash position | 49.20%663.74K | -82.77%444.87K | 160.02%2.58M | 48.23%993.21K | 419.48%670.04K | -84.24%128.98K | -51.92%818.55K | 698.59%1.7M | 724.11%213.2K | 10,546.09%25.87K |
| Current changes in cash | 172.41%596.24K | 110.24%218.87K | -234.50%-2.14M | 391.80%1.59M | -40.27%323.17K | 178.46%541.06K | 22.00%-689.57K | -159.36%-884.03K | 695.07%1.49M | 630.98%187.33K |
| End cash Position | 89.83%1.26M | 49.20%663.74K | -82.77%444.87K | 160.02%2.58M | 48.23%993.21K | 419.48%670.04K | -84.24%128.98K | -51.92%818.55K | 698.59%1.7M | 724.11%213.2K |
| Free cash from | -149.66%-4.01M | 24.81%-1.61M | 36.93%-2.14M | -49.32%-3.39M | -171.54%-2.27M | 22.83%-835.93K | 63.56%-1.08M | -108.25%-2.97M | 32.13%-1.43M | -203.89%-2.1M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |